Pharminent

Novartis to acquire Ziarco to expand dermatology portfolio

Novartis has agreed to acquire Ziarco Group, a privately held firm engaged in the development of novel treatments in dermatology. http://drugdiscovery.pharmaceutical-business-review.com/news/novartis-to-acquire-ziarco-to-expand-dermatology-portfolio-191216-5700215

Filed under: Company